Bivalirudin

Drug Status in USA : Approved
Drug Status in Canada : Approved

Indication : Why is this medication prescribed?

Angina, non-ST segment elevated myocardial infarction patients, ST segment elevated myocardial infarction patients undergoing? PCI.

Contraindication: What are the special precautions to be followed?

Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersentisitivity. History of bleeding disorders, active bleeding. Severe uncontrolled hypertension. Sub acute bacterial endocarditis. Severe renal failure and patietns of? hemodialysis.

Other Precaution to be observed while taking this medication

Pregnancy and history of bleeding disorders.

What are possible side effects of this medication ?

Bleeding, bodyache, nausea, headache and hypotension.

Drug Category/Class

  • Direct Thrombin Inhibitors
  • Antithrombotic Agents
  • Blood and Blood Forming Organs
  • Antithrombins
  • Direct thrombin inhibitors
Prescribed For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing p...
Weight :2180.2853
Structure Bivalirudin
Generic Drug Bivalirudin prescribed For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing p...
Formula

C98H138N24O33

Bivalirudin has 2 Brands listed


Bivasave (250 mg)Bivastat

Search Generic Drugs alphabetically